RNAZ
TransCode Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD6.21
+0.97 (+18.51%)
Rating:B-
Company Profile
CEO
Philippe Calais
IPO Date
2021-07-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$5.15
Prev. Close
$5.24
Day Low
$4.97
Day High
$6.30
52W Low
$3.82
52W High
$20.99
Market Cap
$0.01B
Volume
0.05M